Who owns ZEROID?
ZEROID is owned by Neopharm (South Korea, KRX: 092730).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: NeoPharm Co., Ltd. Business Report (사업보고서) for fiscal year 2025, filed with DART, 16 March 2026. Last checked .
Key facts
- Current owner
- NeoPharm Co., Ltd. reported
- Owner HQ
- 🇰🇷 South Korea, Daejeon
- Origin
- 🇰🇷 South Korea, Daejeon
- Founded
- 2002
- Category
- Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
- Parent ticker
- KRX: 092730
- Last verified
- · 2 sources
About ZEROID
ZEROID is a medical skin care brand that Neopharm launched in 2002 and sells mainly through paediatric and dermatology clinics in Korea; the name joins ZERO and STEROID. Exports to Singapore and Indonesia began with its Intensive line in 2010, its MD line was certified as a medical device in Korea in 2014, and its Defensamide ingredient won a silver award at in-cosmetics in 2011.
Ownership timeline of ZEROID
Where ZEROID sits in Neopharm
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Neopharm ownership tree →
See the full Neopharm brand portfolio (5) →
Other brands owned by Neopharm
Neopharm controls 5 brands on Brandtree, 5 of them in personal care & beauty.
Also in personal care & beauty
Other brands in dermocosmetics & clinical skin care, and who owns them
The 48 brands in dermocosmetics & clinical skin care on Brandtree belong to 27 owners. The largest is Ego Pharmaceuticals, with 9; Neopharm has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| DermAid | Ego Pharmaceuticals | 🇦🇺 Australia |
| Biretix | Cantabria Labs | 🇪🇸 Spain |
| CeraVe | L'Oréal | 🇫🇷 France |
| A-Derma | Pierre Fabre | 🇫🇷 France |
| Dermalogica | Unilever | 🇬🇧 United Kingdom |
| Minon | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| Alastin | Galderma | 🇨🇭 Switzerland |
| Celapi | Able C&C | 🇰🇷 South Korea |
Every brand in dermocosmetics & clinical skin care and its owner →
About the owner: Neopharm
Neopharm is a publicly listed company headquartered in Daejeon, South Korea, founded in 2000. Brandtree records 5 brands under its control, and it is listed as KRX: 092730.
Neopharm is a Daejeon skin care company founded in July 2000 that builds its products on MLE, its own formulation that mimics the lipid structure of healthy skin. It has been listed on KOSDAQ since January 2007. Its largest shareholder is the cosmetics group It's Hanbul, which with related parties held 41.34 per cent after buying more shares in October 2025. Sales in 2025 were 132.1 billion won, of which 25.9 billion won were exports.
🇰🇷 ZEROID and other South Korean brands
Brandtree records a controlling owner for 237 brands that began in South Korea. 12 of them (5%) are now controlled by a company headquartered in another country; ZEROID is not one of them.
Frequently asked questions
Who is the parent company of ZEROID?
The parent company of ZEROID is Neopharm, a publicly listed company headquartered in South Korea.
Is ZEROID South Korean?
Yes. ZEROID originated in South Korea in 2002 and its owner, Neopharm, is also headquartered in South Korea.
Is ZEROID still owned by Neopharm?
Yes. As of 28 October 2026, ZEROID is still owned by Neopharm. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] NeoPharm Co., Ltd. Business Report (사업보고서) for fiscal year 2025, filed with DART — NeoPharm Co., Ltd., Stock exchange filing, published 16 March 2026; retrieved 28 October 2026.
- [2] 제로이드 ZEROID – 메디컬 스킨케어 브랜드 | 네오팜 — NeoPharm Co., Ltd., Official document; retrieved 28 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.